Skip to content
TrialScanner

NCT04358068

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Phase 2TerminatedTEVACollaborator

Registry record

Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
COVID-19; SARS-CoV 2
Primary completion
Jul 8, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04358068 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04358068: Evaluating the Efficacy of... | TrialScanner